The Dermatological Drugs Clinical Pipeline 2024
Release Date: Q3' 2024
Number of Candidates: 236
Synopsis: With an aging world population and rising expectations about skin, hair, and nail appearance, the prevalence of some of the most common skin disorders continues to rise. With the exception of Melanoma, most skin disorders are not life threatening. However, they can have serious effects on daily life by causing visible physical damage, embarrassment, and social and occupational restrictions.
Although surgery and other therapies are widely used for the treatment of certain skin conditions, dermatological drugs continue to account for the highest percentage of spending within the wider market for dermatology products, which is driving companies to invest heavily in to the R&D pipeline for the dermatological conditions. The pipeline is covers several therapeutic areas under the dermatological conditions, with several promising candidates in the late stages of the clinical pipeline.
The “Dermatological Drugs Pipeline 2024” excel sheet presents a look at the major drug candidates currently in the clinical pipeline.
The data-set is delivered in an Excel sheet covering clinical drug development pipeline for the dermatological drugs market, profiling 236 future candidates.
The data-set is delivered in an Excel sheet covering clinical drug development pipeline for the dermatological drugs market, profiling 236 future candidates.
For a Sample and Inquiries please contact [email protected]
Pricing: The pipeline excel data sheet is available for the following price:
Single User License: USD 1,200
Company Wide License (Single Site): USD 1,500
Company Wide License (Global Site): USD 2,500
Pipeline Candidates Data Segmentation:
Drug pipeline data set offers a breakdown in the following subcategories:
List of Companies Mentioned:
The following companies and organizations have been mentioned in the pipeline:
AB Science
Abbott Laboratories
AbbVie
Abeona Therapeutics
AbGenomics
Aclaris Therapeutics
Adgero Biopharmaceuticals
AiCuris
Akros Pharma
Alder BioPharmaceuticals
Alexion
Allakos
Allergan
Almirall
Amgen
Amryt Pharma
AnaptysBio
AndroScience Corporation
Angimmune
AOBiome
Apexigen
Arbor Pharmaceuticals
Arcutis
arGentis Pharmaceuticals
Arrevus
Asana BioSciences
AstraZeneca
Athenex
Atox Bio
Autotelic
Bausch Health Companies
Bayer Pharmaceuticals
Beijing Wenfeng Tianji Pharmaceuticals
Berg Pharma
Biocon
Biofrontera
Biogen
BioMimetix
Bioniz
BioPharmX Corporation
Biothera
BMS (Bristol-Myers Squibb)
Boehringer Ingelheim
Botanix Pharmaceuticals
Brickell Biotech
Cadila Pharmaceuticals,
Cambridge Antibody Technology
Can-Fite BioPharma
Cara Therapeutics
Cassiopea
Castle Creek Pharma
Celgene Corporation
Celtaxsys
Cerbios-Pharma
Chugai Pharmaceutical
Cipher Pharmaceuticals
Clinuvel Pharmaceuticals
Coherus BioScience
Concert Pharmaceuticals
Corbus Pharmaceuticals
Creabilis SA
Croma Pharma
Cumberland Pharmaceuticals
Cutanea Life Sciences
Cytori
Debiopharm
Dermata Therapeutics
Dermavant Sciences
Dermira Tanox
Dr Reddys Laboratories
DS Biopharma
Eirion Therapeutics
Birken GmbH
Eisai Co Ltd
Eli Lilly and Company
Elios Therapeutics
Elorac
EMD Serono
Encorafenib
Escalier Biosciences
Evelo Biosciences
Exelixis
Exicure
Fibrocell Science
Foamix
Forward Pharma
Fresenius Kabi
G&E Herbal Biotechnology
Novella Clinical
Galapagos
Galderma
Galectin Therapeutics
Genentech (Roche)
Gilead Sciences
Glenmark Pharmaceuticals
GSK (GlaxoSmithKline)
Hallux
Hapten Sciences
HedgePath Pharmaceuticals
Histogen Inc
Hoth Therapeutics
Hovione
Hugel
Huya Bioscience
iCo Therapeutics
Idera Pharmaceuticals
Immune Pharmaceuticals
Incyte Corporation
InflaRx
Innovation Pharmaceuticals
Intrexon Corporation
Iovance Biotherapeutics
Janssen Biotech
Japan Tobacco
Jiangsu Hengrui Medicine
Kadmon Holdings
Kiniksa Pharmaceuticals
Krystal Biotech
LEO Pharma
Lipidor
Lycera
Maruho Company
Medimetriks Pharmaceuticals
MedImmune
Medivir
Melinta Therapeutics
Menlo Therapeutics
Merck
MicuRx Pharmaceuticals
miRagen Therapeutics
Moberg Pharma
Momenta Pharmaceuticals
MorphoSys
Motif Bio
Mycovia Pharmaceuticals
Mylan
N&N Pharmaceuticals
Nabriva Therapeutics
Nanology
NantKwest
Nektar
Neumedicines
NewLink Genetics
Nielson BioSciences
NovaBiotics
Novan
Novartis
Nowarta Biopharma
Octapharma
Oncolys Biopharma
Oncosec Medical
Ortho Dermatologics
Patagonia Pharmaceuticals
PellePharm
Pfizer
Philogen
Phio Pharmaceuticals
Photocure
Photogen Technologies Inc.
Polichem (Almirall)
PolyMedix
Polynoma
Portola Pharmaceuticals
Principia Biopharma
Promius Pharma
ProQR Therapeutics
Provectus Biopharmaceuticals
Purdue Pharma
Qurient
Ralexar Therapeutics
Realm Therapeutics
Reata Pharmaceuticals
Regeneron Pharmaceutical
Revance Therapeutics
Roche
Roivant Sciences
R-Pharm
Samumed
Sanofi
Santalis Healthcare
Sienna Biopharmaceuticals
Signum Biosciences
Sol-Gel Technologies
Soligenix
Sun Pharmaceutical
Syndax Pharmaceuticals
Takara Bio
Taro Pharmaceutical
Theravance Biopharma
Tioga Pharmaceuticals
Trevi Therapeutics
UCB
Vanda Pharmaceuticals
Veloce BioPharma
Verrica Pharamceuticals
VidacPharma
VielaBio
Viralytics
Vitae Pharmaceuticals
Vitaeris
XBiotech
XenoPort
Ziarco
Oncotelic
Pricing: The pipeline excel data sheet is available for the following price:
Single User License: USD 1,200
Company Wide License (Single Site): USD 1,500
Company Wide License (Global Site): USD 2,500
Pipeline Candidates Data Segmentation:
Drug pipeline data set offers a breakdown in the following subcategories:
- Candidate (Name)
- Drug Developer(s)
- Category/Therapeutic Area(s)
- Acne & Rosacea
- Acne Vulgaris
- Papulopustular Rosacea
- Alopecia
- Alopecia Areata
- Androgenetic Alopecia
- Dermatitis
- Atopic Dermatitis
- Contact Dermatitis
- Psoriasis
- Nail Psoriasis
- Plaque Psoriasis
- Psoriatic Arthritis
- Skin & Fungal Infections
- ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
- Onychomycosis
- Skin and soft tissue infections (SSTIs)
- Skin Cancer
- BCC (Basal Cell Carcinoma)
- Cutaneous T-cell lymphoma (CTCL)
- Melanoma
- MCC (Merkel Cell Carcinoma)
- SCC (Squamous Cell Carcinoma)
- Other Indications
- Actinic Keratosis
- Cutaneous Lupus Erythematosus (CLE)
- Dermatomyositis
- EB (Epidermolysis Bullosa)
- Pemphigus Vulgaris
- Pruritus
- Systemic scleroderma
- Vitiligo
- Warts
- Urticaria
- Others
- Multiple Indications
- Acne & Rosacea
- Phase
- Phase I
- Phase I/II
- Phase II
- Phase II/III
- Phase III
- Pre-Clinical
- Pre-Registration
List of Companies Mentioned:
The following companies and organizations have been mentioned in the pipeline:
AB Science
Abbott Laboratories
AbbVie
Abeona Therapeutics
AbGenomics
Aclaris Therapeutics
Adgero Biopharmaceuticals
AiCuris
Akros Pharma
Alder BioPharmaceuticals
Alexion
Allakos
Allergan
Almirall
Amgen
Amryt Pharma
AnaptysBio
AndroScience Corporation
Angimmune
AOBiome
Apexigen
Arbor Pharmaceuticals
Arcutis
arGentis Pharmaceuticals
Arrevus
Asana BioSciences
AstraZeneca
Athenex
Atox Bio
Autotelic
Bausch Health Companies
Bayer Pharmaceuticals
Beijing Wenfeng Tianji Pharmaceuticals
Berg Pharma
Biocon
Biofrontera
Biogen
BioMimetix
Bioniz
BioPharmX Corporation
Biothera
BMS (Bristol-Myers Squibb)
Boehringer Ingelheim
Botanix Pharmaceuticals
Brickell Biotech
Cadila Pharmaceuticals,
Cambridge Antibody Technology
Can-Fite BioPharma
Cara Therapeutics
Cassiopea
Castle Creek Pharma
Celgene Corporation
Celtaxsys
Cerbios-Pharma
Chugai Pharmaceutical
Cipher Pharmaceuticals
Clinuvel Pharmaceuticals
Coherus BioScience
Concert Pharmaceuticals
Corbus Pharmaceuticals
Creabilis SA
Croma Pharma
Cumberland Pharmaceuticals
Cutanea Life Sciences
Cytori
Debiopharm
Dermata Therapeutics
Dermavant Sciences
Dermira Tanox
Dr Reddys Laboratories
DS Biopharma
Eirion Therapeutics
Birken GmbH
Eisai Co Ltd
Eli Lilly and Company
Elios Therapeutics
Elorac
EMD Serono
Encorafenib
Escalier Biosciences
Evelo Biosciences
Exelixis
Exicure
Fibrocell Science
Foamix
Forward Pharma
Fresenius Kabi
G&E Herbal Biotechnology
Novella Clinical
Galapagos
Galderma
Galectin Therapeutics
Genentech (Roche)
Gilead Sciences
Glenmark Pharmaceuticals
GSK (GlaxoSmithKline)
Hallux
Hapten Sciences
HedgePath Pharmaceuticals
Histogen Inc
Hoth Therapeutics
Hovione
Hugel
Huya Bioscience
iCo Therapeutics
Idera Pharmaceuticals
Immune Pharmaceuticals
Incyte Corporation
InflaRx
Innovation Pharmaceuticals
Intrexon Corporation
Iovance Biotherapeutics
Janssen Biotech
Japan Tobacco
Jiangsu Hengrui Medicine
Kadmon Holdings
Kiniksa Pharmaceuticals
Krystal Biotech
LEO Pharma
Lipidor
Lycera
Maruho Company
Medimetriks Pharmaceuticals
MedImmune
Medivir
Melinta Therapeutics
Menlo Therapeutics
Merck
MicuRx Pharmaceuticals
miRagen Therapeutics
Moberg Pharma
Momenta Pharmaceuticals
MorphoSys
Motif Bio
Mycovia Pharmaceuticals
Mylan
N&N Pharmaceuticals
Nabriva Therapeutics
Nanology
NantKwest
Nektar
Neumedicines
NewLink Genetics
Nielson BioSciences
NovaBiotics
Novan
Novartis
Nowarta Biopharma
Octapharma
Oncolys Biopharma
Oncosec Medical
Ortho Dermatologics
Patagonia Pharmaceuticals
PellePharm
Pfizer
Philogen
Phio Pharmaceuticals
Photocure
Photogen Technologies Inc.
Polichem (Almirall)
PolyMedix
Polynoma
Portola Pharmaceuticals
Principia Biopharma
Promius Pharma
ProQR Therapeutics
Provectus Biopharmaceuticals
Purdue Pharma
Qurient
Ralexar Therapeutics
Realm Therapeutics
Reata Pharmaceuticals
Regeneron Pharmaceutical
Revance Therapeutics
Roche
Roivant Sciences
R-Pharm
Samumed
Sanofi
Santalis Healthcare
Sienna Biopharmaceuticals
Signum Biosciences
Sol-Gel Technologies
Soligenix
Sun Pharmaceutical
Syndax Pharmaceuticals
Takara Bio
Taro Pharmaceutical
Theravance Biopharma
Tioga Pharmaceuticals
Trevi Therapeutics
UCB
Vanda Pharmaceuticals
Veloce BioPharma
Verrica Pharamceuticals
VidacPharma
VielaBio
Viralytics
Vitae Pharmaceuticals
Vitaeris
XBiotech
XenoPort
Ziarco
Oncotelic
Our Research & Services |
Company |
MoreSubscribe for Latest Updates
Privacy Policy Disclosures Contact Us: [email protected] © 2025 SNS Research |